StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by homerunstockon Aug 12, 2016 10:23am

216 Views

Post# 25135281

Multiple Client Contracts In Discussions !!

The first contract looks very Imminent but I fully expect multiple deals before year end - for starters looking for a very near term target of .60 remember we now own 100% of the Company as stated before other USA competitors are trading in the $5.00 to $25.00 us range - great risk reward here to get in on the ground floor of a multi bagger !!!

Bullboard Posts

Transportation technology stock secures second major contract in a week